Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Endocrinology
Disease Category: Diabetes Mellitus, Type 1

Trial Information

Type 1 Diabetes Trial- Outpatient study for patients that are recently diagnosed (within 90 days), between 18 and 35 years old, and insulin dependent.

Type 1 Diabetes Trial- Outpatient study for patients that are recently diagnosed (within 90 days), between 18 and 35 years old, and insulin dependent. Doctors Visits, Medication, and Lab Assessments will be included at no charge. In addition, eligible subjects earn up to $1,200 for participation if they complete the study

Patient Inclusion Criteria:

• 18-35 years old
• Type I Diabetes
• BMI must be < 32.0

Must NOT:

• Be using Inhaled Insulin
• Have Hepatitis B or C
• Have not used any investigational drug within the 3 months
• Have donated blood within 30 days of screen
• Have used any potent immunosuppressive agent within the past 30 days
• Have not used any atypical antipsychotic drug within the past 30 days
• Have received a vaccine within the past 30 days
• Have previously received otelixizumab or any other anti-CD3 monoclonal antibody
• Have not received any anti-lymphocyte monoclonal antibody, such as anti-CD20, anti-thymocyte globulin (ATG), rituximab (Rituxan®), or alemtuzumab(Campath®)
• An allergic reaction, including anaphylaxis, to any human, humanized, chimeric, orrodent antibody
• Have undergone any major surgical procedure within the past 30 days

Clinical Innovations
3634 Elizabeth St., Suite B
Riverside, CA 92506
Phone: 866-4STUDY1 (866-478-8391)
EMail: volunteers@citrials.com

View Google Map

DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.